CClinicalTrials.gg
Status unknownNCT02506725quarentaUpdated Aug 28, 2019

Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity

An interventional study of prenatal care in groups in Pregnancy, sponsored by Oswaldo Cruz Foundation. Status unknown at 1 site in Brazil. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-08-28.

Sponsored by Oswaldo Cruz Foundation · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of Quarenta Semanas is to remove risk factors for preterm birth by linking women to prenatal care in the first trimester; supporting, educating and empowering women in pregnancy to reduce maternal stress and interrupt social, psychological, attitudinal and biological risk factors for preterm birth; and providing evidence-based, quality care that identifies and intervenes medically to treat underlying chronic and emergent conditions associated with preterm birth.

Read the detailed description

Brazil is among 10 countries with the highest rates of preterm birth (12.4%). Alarmingly, rates are rising. Research has identified multiple risk factors for preterm birth, which can be grouped into four domains, all of which must be addressed to result in meaningful reductions in preterm birth. Domain 1: Access to and utilization of prenatal care. With universal access to prenatal and postpartum care assured via Brazil's Stork Network, Community Health Workers will conduct neighborhood outreach to identify women early in pregnancy and assure that women use prenatal services in the first trimester.

Domain 2: Maternal social, demographic and attitudinal risk factors include maternal stress, lack on knowledge about pregnancy, lack of social support, feeling low control over their health and pregnancy care, unplanned or unwanted pregnancy, unsatisfactory relationship with the father, social isolation, and short interpregnancy interval. Maternal demographic characteristics (e.g., Black race, being single, maternal age under 21 or over 35 years, and poverty) are helpful for identifying high-risk women, but are less amenable to interventions to prevent preterm birth. Domain 3: Maternal physical health risk factors include prior preterm birth, multiple gestation, infection, mucosal or systemic immune responses, diabetes, under and overweight, and hypertension. Several of these factors may be prevented or treated with optimal medical care. Domain 4: Quality of prenatal care includes completing all prenatal care visits, provider compliance with prenatal care guidelines, access to recommended tests or equipment, and appropriate referral of high-risk pregnant women to specialty care. QS is designed to attenuate the effects of risk factors for preterm births in each of these four domains through early access to high quality prenatal care delivered in a group model. STUDY DESIGN The Randomized Trial Framework. We will implement QS in the context of a RCT. We recruited 4 clinics in the Stork Network that serve the same patient population and geographic area in the central and west area of Rio de Janeiro. We will pair them into 2 dyads matched by number of prenatal patients served. We will randomly assign one clinic in each dyad to implement QS and the other will continue to deliver care as usual. Below, when we describe activities related to QS, they will be done only in the 2 QS clinics; in the control clinics, we will collect data only. The clinics or Health Municipal Centers belong to the Municipal Health System. They are staffed by Family Doctors, Nurses and Health Agents and look after a specific geographic location. They provide prenatal care and are able to perform laboratory tests, X-rays and obstetrical ultrasonography. Clinics selected for this project follow at least 250 pregnant women per year. The 2 QS sites are intervention sites and two are control sites. All sites have WiFi or wired internet access for REDCap survey administration, which is web based. The targeted enrollment is 240 QS women, 20 groups of 12 women. In each of the two QS clinical sites, we will form one group per month for 10 months, totaling 20 groups. We will enroll an equivalent number of women in the control clinics matching the pace of recruitment in the QS clinics. We will track that the appropriate number of groups are started and that the meetings occur monthly from 16-32 weeks and then biweekly thereafter until delivery. The "Centering Care Pregnancy" methodology will be used in the intervention clinics in prenatal care in groups.

02

Conditions studied

  • Pregnancy

Browse trials for

Keywords

  • prenatal care
  • pregnancy
  • prematurity
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 240 is above the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Oswaldo Cruz Foundation is the lead sponsor of 42 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

In order to be eligible to participate in this study:

  • women must be at least eighteen years old and pregnant.
  • They must be less than 12 weeks pregnant at the time of enrollment.
  • They must speak Portuguese.
  • Multiple gestation pregnancies will be excluded.

Exclusion criteria

Exclusion Criteria:

  • women who submit reasons not to take part groups after applying the questionnaire
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
240 participants (actual)

Study arms

  • Experimental
    Prenatal Care in groups

    We will do prenatal care using centering care pregnancy methodology in 10 sessions

    Other: prenatal care in groups

  • No intervention
    Control Group

    We will do in this arm conventional Prenatal care available in the family clinics

Interventions

  • Otherprenatal care in groups

    We will do prenatal care in groups using centering care pregnancy methodology

    Also known as: centering care for prenatal

06

What researchers measure

Primary outcomes

  1. prematurity rate

    birth before 37 weeks of gestational age

    Time frame: 12 months

Secondary outcomes

  1. mothers satisfaction

    scale to do measurement of mothers satisfaction

    Time frame: 12 months

  2. vaginal birth

    % of normal birth

    Time frame: 12 months

07

Study locations

1 site
  • Maria Elisabeth Moreira
    Rio de Janeiro, RJ 22250020, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02506725
Lead sponsor
Oswaldo Cruz Foundation
Collaborators
Montefiore Medical Center
Responsible party
Maria Elisabeth Lopes Moreira (MD,PHD, Oswaldo Cruz Foundation) — Principal investigator
First posted
Jul 23, 2015
Start date
Aug 2015
Primary completion
Sep 1, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Aug 28, 2019

Study contacts

Shioban Dolan, MD
study director · Montefiore Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion